Towards novel anti-cancer agents: Tetrahydroquinoline-based small-molecules as selective Mcl-1 inhibitors

被引：0
|
作者：
Chen, Lijia [1 ]
Yap, Jeremy L. [1 ]
Gallagher, Catherine [2 ,3 ]
Walensky, Loren D. [2 ,3 ]
Fletcher, Steven [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02215 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
326-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
    Bolomsky, Arnold
    Vogler, Meike
    Kose, Murat Cem
    Heckman, Caroline A.
    Ehx, Gregory
    Ludwig, Heinz
    Caers, Jo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [2] MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
    Arnold Bolomsky
    Meike Vogler
    Murat Cem Köse
    Caroline A. Heckman
    Grégory Ehx
    Heinz Ludwig
    Jo Caers
    Journal of Hematology & Oncology, 13
  • [3] Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
    Arnold Bolomsky
    Meike Vogler
    Murat Cem Köse
    Caroline A. Heckman
    Grégory Ehx
    Heinz Ludwig
    Jo Caers
    Journal of Hematology & Oncology, 14
  • [4] Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents
    Wan, Yichao
    Dai, Ningning
    Tang, Zilong
    Fang, Hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 146 : 471 - 482
  • [5] Discovery of orally bioavailable novel Mcl-1 inhibitors that exhibit selective anti-proliferative activity in Mcl-1 sensitive cancer cell lines
    Lee, Taekyu
    Bian, Zhiguo
    Belmar, Johannes
    Shaw, Subrata
    Tarr, James C.
    Zhao, Bin
    Pelz, Nick
    Camper, DeMarco
    Goodwin, Craig M.
    Arnold, Allison L.
    Sensintaffar, John L.
    Browning, Carrie F.
    Rossanese, Olivia W.
    Olejniczak, Edward T.
    Fesik, Stephen W.
    CANCER RESEARCH, 2016, 76
  • [6] Small molecule Mcl-1 inhibitors for the treatment of cancer
    Belmar, Johannes
    Fesik, Stephen W.
    PHARMACOLOGY & THERAPEUTICS, 2015, 145 : 76 - 84
  • [7] MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (vol 13, 173, 2020)
    Bolomsky, Arnold
    Vogler, Meike
    Koese, Murat Cem
    Heckman, Caroline A.
    Ehx, Gregory
    Ludwig, Heinz
    Caers, Jo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [8] Novel Mcl-1 inhibitors for pancreatic cancer therapy
    Nikolovska-Coleska, Z.
    Bajwa, N.
    Liu, M.
    Azmi, A.
    Stuckey, J.
    Tomita, Y.
    Mohammad, R.
    Fu, H.
    EJC SUPPLEMENTS, 2010, 8 (07): : 94 - 94
  • [9] Selective small molecule inhibition of anti-apoptotic MCL-1
    Cohen, Nicole A.
    Stewart, Michelle L.
    Gavathiotis, Evripidis
    Tepper, Jared L.
    Opferman, Joseph T.
    Walensky, Loren D.
    CANCER RESEARCH, 2012, 72
  • [10] Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
    Kaushal Parikh
    Shundong Cang
    Arunabh Sekhri
    Delong Liu
    Journal of Hematology & Oncology, 7
12345